Just an update on Astra Zenecas OA pain targeting trial.
It has now completed its phase 2 trial. I believe it is targeting pain only. I can't find any info on whether it's phase 2 was a success or not/adverse events etc...
Link to trial for those interested
https://clinicaltrials.gov/study/NCT04675034?term=NCT04675034&rank=1
Paradigm Competition, page-12
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $113.4K | 575.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 27738 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 170164 | 6 |
View Market Depth
| Last trade - 12.28pm 09/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |